Stock Market Today: Dow, S&P 500, Nasdaq Slide as Treasury Yields Rise and Oil Jumps
Bitcoin and Ethereum Hold Near Key Levels as Crypto Investors Debate Whether the Bottom Is In
Bitcoin and Ethereum started the week on shaky footing Monday as the crypto market struggled to find direction after months of weakness.
Stock Market Today: Dow, S&P 500, Nasdaq Slip as Iran Standoff and Inflation Fears Pressure Stocks
SMX Backs Its “Truth Layer” With $50M in New Capital as Global Mandates Grow
Strategy Sells More Bitcoin as Michael Saylor Shifts From Accumulation to Balance-Sheet Defense
Business & Market Movers
Breaking News
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled “Low Glycemic Sugar Composition.”
Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled “Low Glycemic Sugar Composition” developed within this platform.
Bruush Oral Care Inc. and Arrive Technology Inc. Announce Agreement and Plan of Merger
scdadmin·Dec 15, 2023
Deep Dive & Research
Healthcare & Biotech
Eli Lilly Stock Climbs as GLP-1 Demand Fuels Higher Sales Outlook
Eli Lilly (LLY) shares surged on Wednesday after the pharmaceutical giant raised its full-year sales forecast and delivered second-quarter results that beat expectations.
Join our newsletter
Read and share new perspectives on just about any topic. Everyone’s welcome.- 01Create a free account
- 02Write your story
Tech & Energy
CoreWeave Stock Soars as AI Demand and Backlog Growth Signal a Turning Point
CoreWeave (CRWV) surged approximately 20% Wednesday after the AI cloud provider delivered stronger-than-expected second-quarter results and raised its full-year outlook, giving investors new evidence that massive spending on AI infrastructure is translating into rapid revenue growth.
Tech Stocks Face Critical Test as Microsoft and Meta Earnings Put AI Spending Under the Microscope
